Biosimilars and what’s new in cell and gene therapies

Beyond Biotech - the podcast from Labiotech

This week on the podcast, we have a conversation with Fran Gregory, vice president of Emerging Therapies at Cardinal Health.

The discussion covers the company’s role in healthcare, biosimilars, the latest in cell and gene therapies, and what’s new at Advanced Therapies Week.

00:40-02:30: About Cardinal Health
02:30-05:12: What is Cardinal Health’s role in industry?
05:12-06:11: What are the challenges of logistics?
06:11-07:20: How important is innovation to Cardinal Health?
07:20-12:26: How can Cardinal Health help to reduce costs?
12:26-13:08: Keeping up with global healthcare
13:08-19:46: How do you stay in touch with what’s new in drug discovery?
19:46-22:07: Biosimilars Report
22:07-27:15: What is the current state of the cell and gene therapy space?
27:15-29:57: Are there interesting recent advances in the cell and gene therapy?
29:57-33:38: Advanced Therapies Week
33:38-36:40: What trends are you expecting in 2024?
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

Kapitel

1. Biosimilars and what’s new in cell and gene therapies (00:00:00)

2. About Cardinal Health (00:00:40)

3. What is Cardinal Health’s role in industry? (00:02:30)

4. What are the challenges of logistics?
 (00:05:12)

5. How important is innovation to Cardinal Health? (00:06:11)

6. How can Cardinal Health help to reduce costs?
 (00:07:20)

7. Keeping up with global healthcare
 (00:12:26)

8. How do you stay in touch with what’s new in drug discovery?
 (00:13:08)

9. Biosimilars Report (00:19:46)

10. What is the current state of the cell and gene therapy space?
 (00:22:07)

11. Are there interesting recent advances in the cell and gene therapy?
 (00:27:15)

12. Advanced Therapies Week
 (00:29:57)

13. What trends are you expecting in cell and gene therapy in 2024?
 (00:33:38)